Search results
Showing 2641 to 2655 of 9071 results
Awaiting development Reference number: GID-TA10519 Expected publication date: TBC
In development Reference number: GID-TA10664 Expected publication date: TBC
Awaiting development Reference number: GID-TA11069 Expected publication date: TBC
Masitinib with riluzole for treating amyotrophic lateral sclerosis [ID6257]
In development Reference number: GID-TA11071 Expected publication date: TBC
Edaravone for treating amyotrophic lateral sclerosis [TSID11869]
Awaiting development Reference number: GID-TA11362 Expected publication date: TBC
Awaiting development Reference number: GID-TA11527 Expected publication date: TBC
Awaiting development Reference number: GID-TA11773 Expected publication date: 27 May 2027
In development Reference number: GID-TA11356 Expected publication date: TBC
In development Reference number: GID-TA11768 Expected publication date: 28 October 2026
Sugemalimab with chemotherapy for untreated advanced non-small-cell lung cancer [ID6758]
In development Reference number: GID-TA12462 Expected publication date: TBC
Sarizotan for the treatment of respiratory symptoms associated with Rett syndrome [ID1506]
Awaiting development Reference number: GID-TA10662 Expected publication date: TBC
PXT3003 for treating Charcot-Marie-Tooth disease type 1A in people aged 16 and over [ID1439]
Awaiting development Reference number: GID-TA11325 Expected publication date: TBC
Adalimumab for treating early Dupuytren's contracture [ID6276]
Awaiting development Reference number: GID-TA11363 Expected publication date: TBC
Awaiting development Reference number: GID-TA10346 Expected publication date: TBC
Awaiting development Reference number: GID-TA11840 Expected publication date: TBC